Amarin Corp Plc (AMRN)

[massulo52]

$AMRN Dyslipidemia Clinical Practice Guidelines (2019)
European Society of Cardiology (ESC), European Atherosclerosis Society (EAS)

Pharmacotherapy of patients with hypertriglyceridemia (should be considered)

In high-risk (or above) patients with triglyceride (TG) levels between 1.5 and 5.6 mmol/L (135-499 mg/dL) despite statin treatment, consider the combination of n-3 polyunsaturated fatty acids (PUFAs) (icosapent ethyl 2 × 2g/day) with statins.

October 08, 2019